BEDMINSTER, NJ—MCS, a healthcare communications specialist, has named Jeff Hoyak as president and announced an expansion of the agency’s executive committee. The restructuring of the leadership group is designed “to enhance the firm’s ability to continue providing award-winning creativity, service and results to the pharmaceutical and biotech industries,” according to chief executive Joe Boyd.
Joining Boyd and Hoyak on the executive committee are newly promoted executive vice president Todd Forte and recently appointed vice presidents Ginger Hall and Olga Silva. Executive vice president Lauren Luik, a 16-year veteran of MCS and a longtime executive committee member, has stepped into a consulting role with the agency.
“As MCS celebrates its 20th year in the healthcare communications field, we are well aware of the increasingly complex challenges facing the pharmaceutical industry,” says Boyd. “Our expanded and reorganized executive team has the strategic leadership and vision to meet our clients’ goals and provide the demonstrable value they need.”
Hoyak’s appointment follows a tenure of 10 years at MCS, where he most recently served as EVP. Prior to joining MCS, he served in a number of public affairs positions at Lederle Laboratories.